By Tom Fox2016-08-23T10:00:00
The Man From FCPA Tom Fox looks at the case of disgraced pharmaceutical company Valeant and what new Chief Financial Officer Paul Herendeen has planned for the company’s future.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-12-22T19:35:00Z By Jaclyn Jaeger
President Donald Trump’s unprecedented misuse and abuse of a pardon power that dates back 250 years serves as a real-world scenario of what can happen when a system of checks-and-balances – like, say, a corporate ethics and compliance program – is upended by a tyrannical executive.
2025-12-02T20:36:00Z Provided by konaAI
This survey will explore how ethics & compliance (E&C) officers are adopting and leveraging artificial intelligence (AI), particularly generative AI, within their programs.
2025-12-01T16:04:00Z By Craig Conte, CW guest columnist
The only thing constant is change. Shouldn’t we be ready for that in our contracts?
Site powered by Webvision Cloud